APA

Hayward R. L., Schornagel Q. C., Tente R., Macpherson J. S., Aird R. E., Guichard S., Habtemariam A., Sadler P. & Jodrell D. I. (20050621). Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175. : Cancer chemotherapy and pharmacology.

Chicago

Hayward R L, Schornagel Q C, Tente R, Macpherson J S, Aird R E, Guichard S, Habtemariam A, Sadler P and Jodrell D I. 20050621. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175. : Cancer chemotherapy and pharmacology.

Harvard

Hayward R. L., Schornagel Q. C., Tente R., Macpherson J. S., Aird R. E., Guichard S., Habtemariam A., Sadler P. and Jodrell D. I. (20050621). Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175. : Cancer chemotherapy and pharmacology.

MLA

Hayward R L, Schornagel Q C, Tente R, Macpherson J S, Aird R E, Guichard S, Habtemariam A, Sadler P and Jodrell D I. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175. : Cancer chemotherapy and pharmacology. 20050621.